Genalyte Receives $500K SBIR Grant for Diabetes Assay Development | GenomeWeb

NEW YORK (GenomeWeb News) – Multiplex assay development firm Genalyte today announced it has been awarded a $500,000 Small Business Innovation Research grant to develop multiplexed diagnostic assays for the early detection and monitoring of type 1 diabetes.

The award is from the National Institute of Diabetes and Digestive and Kidney Diseases. The assays being developed will run on Genalyte's Maverick Detection System, which uses a silicon chip containing arrays of photonic ring sensors for the detection of multiple antibodies and other proteins from a single small sample.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.